In April 2023 the United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the Polish boxer Krzysztof Glowacki after his sample tested positive for the prohibited substance Boldenone. Following notification a provisional suspension was ordered and the Athlete was heard for the National Anti-Doping Panel.
The Athlete denied the intentional use of the substance and stated that prior he had received medical treatment from a doctor in Warsaw for the serious injury to his hand. Yet the Athlete was hampered to provide timely sufficient evidence from a clinic accompanied by an official translation before he attended the hearing.
The Panel determines that the Athlete's medical treatment with (the banned substance) Betamethasone for his injury could not explain the presence of Boldenone in his system. Ultimately the Panel concludes that the Athlete failed to establish with corroborating evidence that the violation was not intentional and that there are no exceptional circumstances.
Therefore the Panel decides on 13 November 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 6 April 2023.
